NAPLEX Flashcards: Immunization And Prevention Programs

Study Immunization And Prevention Programs in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.

NAPLEX

Immunization And Prevention Programs

0 mastered0 still learning

0% Complete

QUESTION
1/ 25

Which meningococcal vaccine type is indicated for serogroup B disease prevention: MenACWY or MenB?

Tap card or press Space to flip

ANSWER

MenB vaccine. MenB targets serogroup B capsular polysaccharides, addressing strains not covered by quadrivalent vaccines.

How well did you know it?

Card 1 / 25

What this deck covers

This deck focuses on Immunization And Prevention Programs, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.

How to use these flashcards

Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.

All flashcards

Flashcard 1: Which meningococcal vaccine type is indicated for serogroup B disease prevention: MenACWY or MenB?

Answer: MenB vaccine. MenB targets serogroup B capsular polysaccharides, addressing strains not covered by quadrivalent vaccines.

Flashcard 2: What is the correct route and anatomic site for most intramuscular (IM) vaccines in adults?

Answer: IM injection in the deltoid muscle. The deltoid muscle offers sufficient mass and accessibility, minimizing risks like nerve damage for IM vaccine delivery in adults.

Flashcard 3: Which condition is a true contraindication to further doses of a vaccine: mild illness or anaphylaxis?

Answer: Anaphylaxis to a prior dose or vaccine component. Severe allergic reactions indicate hypersensitivity, posing a life-threatening risk upon re-exposure.

Flashcard 4: What is the preferred anatomic site for intramuscular (IM) vaccination in infants?

Answer: IM injection in the anterolateral thigh (vastus lateralis). The vastus lateralis provides the largest muscle mass in infants, reducing the risk of hitting nerves or blood vessels.

Flashcard 5: What is the minimum recommended needle length for IM vaccination in most adults?

Answer: Needle length typically 11 inch (adjust for body habitus). A 1-inch needle penetrates the deltoid muscle adequately in average adults, with adjustments ensuring proper depth based on subcutaneous fat.

Flashcard 6: Which hepatitis A vaccination strategy is recommended after exposure for most adults: vaccine or IG only?

Answer: Hepatitis A vaccine as postexposure prophylaxis (IG for select cases). Vaccine induces active immunity effectively for postexposure prophylaxis, with IG reserved for high-risk or contraindicated individuals.

Flashcard 7: Which document must be provided to patients for covered vaccines: VIS or package insert?

Answer: Vaccine Information Statement (VIS). VIS ensures patients receive standardized, understandable information on vaccine benefits, risks, and alternatives as required by law.

Flashcard 8: What is the key counseling point about vaccine series timing if a patient is behind schedule?

Answer: Do not restart; continue the series using minimum intervals. Resuming the series maintains protective immunity without wasting prior doses, using minimum intervals to complete it efficiently.

Flashcard 9: What is the routine recommendation for recombinant zoster vaccine (RZV, Shingrix) in adults?

Answer: Two doses for adults aged 5050 years and older. This regimen boosts cell-mediated immunity against varicella-zoster virus, reducing shingles risk in aging populations.

Flashcard 10: What is the correct management for a patient with a history of Guillain-Barré syndrome after influenza vaccine?

Answer: Use caution; generally avoid if GBS occurred within 66 weeks of a flu vaccine. Prior GBS post-vaccination suggests potential recurrence risk, warranting avoidance unless benefits outweigh risks.

Flashcard 11: What is the preferred postexposure prophylaxis for measles in an unvaccinated susceptible person?

Answer: MMR within 7272 hours or immune globulin within 66 days. Timely MMR stimulates active immunity to prevent infection, while IG offers passive protection if the vaccine window is missed.

Flashcard 12: Which pneumococcal vaccine is a polysaccharide vaccine: PCV or PPSV?

Answer: PPSV2323 is polysaccharide; PCV vaccines are conjugate. PPSV23 consists of purified capsular polysaccharides, eliciting a T-cell independent response, unlike protein-conjugated PCV vaccines.

Flashcard 13: What is the routine hepatitis B vaccination recommendation for adults aged 1919 to 5959 years?

Answer: Universal hepatitis B vaccination for ages 1919 to 5959 years. This policy aims to reduce hepatitis B transmission by vaccinating all in this age group without risk assessment.

Flashcard 14: What is the preferred influenza vaccine type for adults aged 6565 years and older?

Answer: High-dose or adjuvanted inactivated influenza vaccine. These formulations enhance immunogenicity to overcome age-related immune decline in older adults.

Flashcard 15: Identify the correct action if 22 live injectable vaccines were given on different days 77 days apart.

Answer: Repeat the second live vaccine at least 2828 days after the first. Insufficient spacing can cause immune interference from the first vaccine, rendering the second dose ineffective.

Flashcard 16: What is the recommended action after syncope occurs following vaccination?

Answer: Observe the patient seated or supine for about 1515 minutes. This positioning and observation period prevents injury from falls and monitors for complications post-vasovagal reaction.

Flashcard 17: Which vaccine type is contraindicated in pregnancy: live attenuated or inactivated?

Answer: Live attenuated vaccines are contraindicated in pregnancy. These vaccines contain replicating organisms that pose a theoretical risk of infection to the fetus.

Flashcard 18: What is the standard adult tetanus booster schedule when primary series is complete?

Answer: Td or Tdap every 1010 years. Decennial boosters sustain protective antitoxin levels against tetanus and diphtheria in adults.

Flashcard 19: Identify the correct action if an inactivated vaccine is given subcutaneously by mistake.

Answer: Do not repeat dose if valid; document and counsel (repeat only if clearly invalid). Many inactivated vaccines remain immunogenic via subcutaneous route, avoiding unnecessary revaccination unless efficacy is compromised.

Flashcard 20: What is the definition of a Vaccine Adverse Event Reporting System (VAERS) reportable event?

Answer: Any clinically significant adverse event after vaccination. VAERS tracks any notable health issues post-vaccination to identify potential safety signals, regardless of causality.

Flashcard 21: What is the correct route for live attenuated influenza vaccine (LAIV)?

Answer: Intranasal administration. Intranasal delivery enables the attenuated virus to replicate in the upper respiratory tract, stimulating local mucosal immunity against influenza.

Flashcard 22: What is the minimum interval between the 22 doses of recombinant zoster vaccine (RZV)?

Answer: At least 22 months (typically given at 00 and 22 to 66 months). This spacing optimizes the adjuvant-enhanced immune response for long-term protection against herpes zoster.

Flashcard 23: Which hepatitis B vaccine product is a 22-dose series given over about 11 month?

Answer: Heplisav-B: 22 doses separated by at least 44 weeks. Its adjuvanted formulation achieves high seroprotection with fewer doses compared to traditional 3-dose series.

Flashcard 24: Which zoster vaccine is live and generally avoided in immunocompromised patients: RZV or ZVL?

Answer: ZVL (Zostavax) is live; RZV is nonlive recombinant. Live attenuated vaccines can replicate and cause disease in those with impaired immunity, unlike nonlive options.

Flashcard 25: Which tetanus-containing vaccine is recommended during each pregnancy, regardless of prior history?

Answer: Tdap during each pregnancy. Tdap during pregnancy transfers maternal antibodies to the infant, protecting against pertussis in early infancy.